Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41


South African Breast Cancer and HIV Outcomes Study: Methods and Baseline Assessment.

Cubasch H, Ruff P, Joffe M, Norris S, Chirwa T, Nietz S, Sharma V, Duarte R, Buccimazza I, Čačala S, Stopforth LW, Tsai WY, Stavsky E, Crew KD, Jacobson JS, Neugut AI.

J Glob Oncol. 2017 Apr;3(2):114-124. doi: 10.1200/JGO.2015.002675.


Virologic and Immunologic Outcomes in HIV-Infected Patients with Cancer.

Riedel DJ, Stafford KA, Vadlamani A, Redfield RR.

AIDS Res Hum Retroviruses. 2017 May;33(5):482-489. doi: 10.1089/AID.2016.0181. Epub 2016 Dec 13.


Outcomes of abdominoperineal resection for management of anal cancer in HIV-positive patients: a national case review.

Leeds IL, Alturki H, Canner JK, Schneider EB, Efron JE, Wick EC, Gearhart SL, Safar B, Fang SH.

World J Surg Oncol. 2016 Aug 5;14(1):208. doi: 10.1186/s12957-016-0970-x.


Lung Malignancies in HIV Infection.

Sigel K, Pitts R, Crothers K.

Semin Respir Crit Care Med. 2016 Apr;37(2):267-76. doi: 10.1055/s-0036-1578803. Epub 2016 Mar 14. Review.


Cancer prevention in HIV-infected populations.

Goncalves PH, Montezuma-Rusca JM, Yarchoan R, Uldrick TS.

Semin Oncol. 2016 Feb;43(1):173-188. doi: 10.1053/j.seminoncol.2015.09.011. Epub 2015 Sep 8. Review.


Pulmonary Kaposi's sarcoma as the initial presentation of human immunodeficiency virus infection.

Imran TF, Al-Khateeb Z, Jung J, Peters S, Dever LL.

IDCases. 2014 Oct 13;1(4):78-81. doi: 10.1016/j.idcr.2014.10.002. eCollection 2014.


Lung cancer in HIV-infected patients in the combination antiretroviral treatment era.

Moltó J, Moran T, Sirera G, Clotet B.

Transl Lung Cancer Res. 2015 Dec;4(6):678-88. doi: 10.3978/j.issn.2218-6751.2015.08.10. Review.


Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States.

Coghill AE, Shiels MS, Suneja G, Engels EA.

J Clin Oncol. 2015 Jul 20;33(21):2376-83. doi: 10.1200/JCO.2014.59.5967. Epub 2015 Jun 15.


Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers.

Marcus JL, Chao C, Leyden WA, Xu L, Yu J, Horberg MA, Klein D, Towner WJ, Quesenberry CP Jr, Abrams DI, Silverberg MJ.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1167-73. doi: 10.1158/1055-9965.EPI-14-1079. Epub 2015 Feb 24.


Cancer treatment disparities in HIV-infected individuals in the United States.

Suneja G, Shiels MS, Angulo R, Copeland GE, Gonsalves L, Hakenewerth AM, Macomber KE, Melville SK, Engels EA.

J Clin Oncol. 2014 Aug 1;32(22):2344-50. doi: 10.1200/JCO.2013.54.8644. Epub 2014 Jun 30.


The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care.

Vaccher E, Serraino D, Carbone A, De Paoli P.

Oncologist. 2014 Aug;19(8):860-7. doi: 10.1634/theoncologist.2014-0024. Epub 2014 Jun 26. Review.


Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study.

Gotti D, Raffetti E, Albini L, Sighinolfi L, Maggiolo F, Di Filippo E, Ladisa N, Angarano G, Lapadula G, Pan A, Esposti AD, Fabbiani M, Focà E, Scalzini A, Donato F, Quiros-Roldan E; Master Cohort Group.

PLoS One. 2014 Apr 23;9(4):e94768. doi: 10.1371/journal.pone.0094768. eCollection 2014.


Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.

Bohlius J, Valeri F, Maskew M, Prozesky H, Garone D, Sengayi M, Fox MP, Davies MA, Egger M.

Int J Cancer. 2014 Dec 1;135(11):2644-52. doi: 10.1002/ijc.28894. Epub 2014 May 2.


Outcomes and chemotherapy-related toxicity in HIV-infected patients with breast cancer.

Singh SN, Zhu Y, Chumsri S, Kesmodel S, Gilliam BL, Riedel DJ.

Clin Breast Cancer. 2014 Apr;14(2):e53-9. doi: 10.1016/j.clbc.2013.11.002. Epub 2013 Nov 20. No abstract available.


Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.

Rubinstein PG, Aboulafia DM, Zloza A.

AIDS. 2014 Feb 20;28(4):453-65. doi: 10.1097/QAD.0000000000000071. Review.


Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.

Worm SW, Bower M, Reiss P, Bonnet F, Law M, Fätkenheuer G, d'Arminio Monforte A, Abrams DI, Grulich A, Fontas E, Kirk O, Furrer H, De Wit S, Phillips A, Lundgren JD, Sabin CA; D:A:D Study Group.

BMC Infect Dis. 2013 Oct 9;13:471. doi: 10.1186/1471-2334-13-471.


Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.

Uldrick TS, Pipkin S, Scheer S, Hessol NA.

AIDS. 2014 Jan 28;28(3):397-405. doi: 10.1097/QAD.0000000000000030.


Prognosis in HIV-infected patients with non-small cell lung cancer.

Sigel K, Crothers K, Dubrow R, Krauskopf K, Jao J, Sigel C, Moskowitz A, Wisnivesky J.

Br J Cancer. 2013 Oct 1;109(7):1974-80. doi: 10.1038/bjc.2013.545. Epub 2013 Sep 10.


Contribution of HIV infection to mortality among cancer patients in Uganda.

Coghill AE, Newcomb PA, Madeleine MM, Richardson BA, Mutyaba I, Okuku F, Phipps W, Wabinga H, Orem J, Casper C.

AIDS. 2013 Nov 28;27(18):2933-42. doi: 10.1097/01.aids.0000433236.55937.cb.


Human immunodeficiency virus-associated lung malignancies.

Lambert AA, Merlo CA, Kirk GD.

Clin Chest Med. 2013 Jun;34(2):255-72. doi: 10.1016/j.ccm.2013.01.008. Epub 2013 Apr 8. Review.

Supplemental Content

Support Center